An end to uncertainty

The UK Anaphylaxis Campaign, for example, would like legislation on standardized allergen thresholds and risk assessments to define which wording to use, a conclusion also reached by the Integrated Approaches to Food Allergen and Allergy Risk Management (iFAAM) group funded by the European Union. IngateyGen, a biotechnology company in Elizabeth City, North Carolina, has patented a process to produce hypoallergenic peanut plants, and the company hopes to produce other plants as part of a partnership with nearby Fayetteville State University. RNAi and gene-editing techniques (such as CRISPR-Cas9) can allow complex genetic control that would be challenging to achieve with conventional genetic modification (GM) approaches.